Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Genex Services White Paper Examines the Tipping Points of Routine Workers' Compensation Claims
Highlights value of early case management intervention for optimal RTWFebruary 18, 2015 – Wayne, Pa.
Tipping Points: When Good Claims Go Bad
Preventing typical workers’ compensation claims from escalating to high-cost levels resulting in return-to-work (RTW) delays and possible litigation is a recurring challenge.
Social Success: Twitter Chat Allows Workers’ Comp Pros to Share Ideas
Although social media has not been widely embraced across the workers’ comp industry as a top resource for news, the first-ever workers’ comp Twitter Chat tested a new channel for communicating, educating and stimulating ideas among industry participants.
Workers' Comp Leaders to Host First-Ever Industry Twitter Chat
Jan.
Learn More About What It Takes To Achieve URAC Accreditation
Genex Services is a leader in utilization review (UR) and has an advanced position to meet the requirements of California Senate Bill 1160, particularly the accreditation mandate.
Genex Develops Ebola Guidelines for the Workers' Comp Industry
Protocols among first specifically focused on infected workersDecember 17, 2014 – Wayne, Pa. – As health care experts wor